BackProtagonist Therapeutics Overview

Protagonist Therapeutics Gross Profit

Gross Profit analysis for PTGX.

Quarterly Gross Profit

$55.96M
↑ 97.6% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$17.38M
↓ 91.57% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin